365996-04-9

Basic information

• Product Name: tert-butyl 3-Mercaptopyridin-4-ylcarbaMate
• Synonyms: tert-butyl 3-Mercaptopyridin-4-ylcarbaMate
• CAS NO: 365996-04-9
• Molecular Formula: C10H14N2O2S
• Molecular Weight: 226.29536
• Mol File: 365996-04-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: tert-butyl 3-Mercaptopyridin-4-ylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-Mercaptopyridin-4-ylcarbaMate(365996-04-9)
• EPA Substance Registry System: tert-butyl 3-Mercaptopyridin-4-ylcarbaMate(365996-04-9)

Safety Data

• Hazardous Substances Data: 365996-04-9(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3-Mercaptopyridin-4-ylcarbamate is a chemical compound that belongs to the class of mercaptocarbamates. It is a derivative of pyridine and contains a tert-butyl group and a mercapto group. tert-butyl 3-Mercaptopyridin-4-ylcarbaMate has potential applications in the field of medicinal chemistry, particularly in the development of pharmaceuticals for the treatment of diseases. It may also have uses in the synthesis of other organic compounds, as well as in chemical research and development. Its specific properties and potential uses would depend on further exploration and investigation in the laboratory.

Upstream product

• 98400-69-2 N-(4-pyridyl) t-butyl carbamate 
• 7783-06-4 hydrogen sulfide 

Downstream Products

• 273-70-1 thiazolo[5,4-c]-pyridine 

Relevant articles and documents

Diamine derivatives

A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

NOVEL ETHYLENEDIAMINE DERIVATIVES

A compound represented by the following formula (1):Q-Q-T-N(R)-Q-N(R)-T-Q [wherein, R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may have a substituent, or the like; Q2 is a single bond or the like; Q3 represents the following group: -C(R3a)(R4a)-{C(R3b)(R4b)}m1-{C(R3c)(R4c)}m2-{C(R3d)(R4d)}m3-{C(R3e)(R4e)}m4-C(R3f)(R4f)- (in which, R3a to R4e represent hydrogen or the like); T0 represents a carbonyl group or the like; and T1 represents -COCONR- or the like]; or salt thereof, solvate thereof, or N-oxide thereof. The compound is useful as a preventive and/or therapeutic agent for cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

DIAMINE DERIVATIVES

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.